Skip to main
MAZE
MAZE logo

MAZE Market Capitalization Overview

Market Cap: $1.56B as of Nov 4, 2025

$1.56B
Past Month+$369.86M (31.11%)
As of Nov 4, 2025, MAZE has a market capitalization of $1.56B. Over the past 30 days, its market cap has increased by 41.2%, while in the last 12 months, it has increased by .

Market capitalization represents the total value of Maze Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

MAZE Market Cap Formula = Stock Price * Shares Outstanding

The market cap of MAZE helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MAZE Market Cap History

DateMarket CapChange
Nov 3, 2025$1.60B+41.20%
Oct 1, 2025$1.14B+68.47%
Sep 2, 2025$671.80M+2.94%
Aug 1, 2025$652.58M+27.79%
Jul 1, 2025$510.68M-3.64%
Jun 2, 2025$529.95M+14.26%
May 1, 2025$463.81M+6.97%
Apr 1, 2025$433.59M-10.29%
Mar 3, 2025$483.30M-24.77%
Feb 3, 2025$642.41M-6.25%
Jan 30, 2025$685.24M

MAZE End of Year Market Cap History

DateMarket CapChange
2025$1.56B

FAQs About Maze Therapeutics Inc (MAZE) Market Cap

As of Nov 4, 2025, the market capitalization of MAZE is $1.56B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Maze Therapeutics Inc’s market capitalization has increased by 31.11%, changing from $1.19B to $1.56B as of Nov 4, 2025.

In the last 3 months, Maze Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Maze Therapeutics Inc’s market capitalization increased from – in January to – in December, reflecting a — change.

Maze Therapeutics Inc (MAZE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.